112
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways

, , , , , , , , & show all
Pages 19-28 | Published online: 28 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yoshiya Tanaka, Kana Hoshino-Negishi, Yoshikazu Kuboi, Fumitoshi Tago, Nobuyuki Yasuda & Toshio Imai. (2020) Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases. ImmunoTargets and Therapy 9, pages 241-253.
Read now
Sei Muraoka, Junko Nishio, Yoshikazu Kuboi, Toshio Imai & Toshihiro Nanki. (2020) Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases. Expert Opinion on Biological Therapy 20:11, pages 1309-1319.
Read now
Toshihiro Nanki, Toshio Imai & Shinichi Kawai. (2017) Fractalkine/CX3CL1 in rheumatoid arthritis. Modern Rheumatology 27:3, pages 392-397.
Read now

Articles from other publishers (4)

Xinjie Lu. (2022) Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer. Current Medicinal Chemistry 29:41, pages 6228-6246.
Crossref
Naoto Nagata, Guanliang Chen, Liang Xu & Hitoshi Ando. (2022) An Update on the Chemokine System in the Development of NAFLD. Medicina 58:6, pages 761.
Crossref
Zhanyu Yang, Delong Liu, Rui Guan, Xin Li, Yiwei Wang & Bin Sheng. (2021) Potential genes and pathways associated with heterotopic ossification derived from analyses of gene expression profiles. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Laura J. Brylka & Thorsten Schinke. (2019) Chemokines in Physiological and Pathological Bone Remodeling. Frontiers in Immunology 10.
Crossref